Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych MEQs / SAQsAddiction psychiatry — perinatal substance use

Psych MEQs / SAQs · Addiction psychiatry — perinatal substance use

Pregnancy and substance use — OAT, alcohol, NAS, and non-punitive care (MEQ)

FRANZCP-style MEQ on polysubstance use in pregnancy: SBIRT, OAT vs detox, alcohol abstinence/FASD, stimulants, NAS expectation, non-punitive care, postpartum risk.

20 marks20 min2 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 31-year-old woman at 22 weeks’ gestation presents to the antenatal clinic. She injects heroin daily, drinks 8–10 standard drinks most days, smokes 15 cigarettes daily, and uses methamphetamine on weekends. She has had no prior antenatal care this pregnancy. She fears child protection will “take the baby if I tell the truth.” Partner is controlling and accompanies her to visits. (i) Outline a non-punitive assessment and screening approach. (ii) Prioritise management of alcohol, opioids, stimulants, and tobacco with named treatments where relevant. (iii) Explain NAS/NOWS counselling for OAT. (iv) Address IPV, safeguarding, and postpartum planning. (20 marks)

Model answer

Reveal model answerShowHide

(i) Assessment and non-punitive framing. See her alone for part of the visit (IPV safety). Use universal SBIRT-style verbal screening, validate courage in disclosure, and explain that the goal is health for her and the baby — not punishment. Inventory opioids, alcohol, methamphetamine, tobacco: amounts, routes, last use, overdoses, prior OAT, BBV risk, mental health, suicide, housing. Be transparent about mandatory reporting thresholds without weaponising them to force urine tests. Offer toxicology only with consent for clinical planning. Baseline labs (FBC, U&E, LFT, BBV, STI), dating/growth ultrasound pathway, ECG if methadone planned.[5][6][3]

(ii) Substance-specific priorities. Alcohol: counsel complete abstinence (no known safe level; FASD prevention); assess withdrawal risk; thiamine if dependent/malnourished; medically supervised withdrawal if needed; avoid disulfiram.[4] Opioids: recommend OAT with methadone or buprenorphine rather than forced detox; induct/maintain under specialist protocols (methadone start low/go slow, often day-1 range ~10–30 mg oral in tolerant adults with careful review; buprenorphine after adequate withdrawal, maintenance often 8–24 mg SL); obstetric–addiction liaison.[2][3][7] Stimulants: no agonist OAT; MI/contingency management/CBT, residential options if needed, growth and abruption vigilance.[6] Tobacco: behavioural cessation support; consider NRT if behavioural care alone insufficient.[5] Integrated schedule beats multiple disconnected referrals.

(iii) NAS counselling. Explain that babies exposed to opioids (including therapeutic OAT) may show neonatal abstinence/withdrawal — irritable, feeding difficulty, autonomic signs — usually manageable with supportive care and sometimes short neonatal morphine protocols. NAS is expected and treatable, not proof she is a bad mother or that OAT failed. MOTHER-era data can inform methadone vs buprenorphine neonatal trade-offs without forcing switches if she is stable.[1][2][6]

(iv) IPV, safeguarding, postpartum. Document IPV; safety plan; offer confidential resources; do not force disclosure in front of partner. Child protection: collaborative safety planning based on capacity to care, engagement, and supports — not automatic removal for OAT or treatable NAS. Postpartum plan before discharge: continue OAT, take-home naloxone, early addiction and maternity review, mood/psychosis screen, contraception, housing supports — highest relapse/overdose window after birth.[6][7]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this meqs / saq. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure N Engl J Med, 2010.PMID 21142534
  2. [2]Minozzi S, Amato L, Jahanfar S, et al. Maintenance agonist treatments for opiate-dependent pregnant women Cochrane Database Syst Rev, 2020.PMID 33165953
  3. [3]American College of Obstetricians and Gynecologists Committee Opinion No. 711 Summary: Opioid Use and Opioid Use Disorder in Pregnancy Obstet Gynecol, 2017.PMID 28742670
  4. [4]Popova S, Lange S, Probst C, et al. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis Lancet Glob Health, 2017.PMID 28089487
  5. [5]Wright TE, Terplan M, Ondersma SJ, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period Am J Obstet Gynecol, 2016.PMID 27373599
  6. [6]Klaman SL, Isaacs K, Leopold A, et al. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance J Addict Med, 2017.PMID 28406856
  7. [7]American Society of Addiction Medicine The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update J Addict Med, 2020.PMID 32511106
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPlanning ECT for severe depression and discussing neurostimulation tiers (MEQ)Psychopharmacology — ECT and neurostimulationNextPremenstrual dysphoric disorder — assessment and management (MEQ)General adult psychiatry — mood disorders / women's mental health